These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38880161)

  • 1. The cellular-centered view of hypoxia tumor microenvironment: Molecular mechanisms and therapeutic interventions.
    Zhang TQ; Lv QY; Jin WL
    Biochim Biophys Acta Rev Cancer; 2024 Sep; 1879(5):189137. PubMed ID: 38880161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay of long non-coding RNAs and HIF-1α: A new dimension to understanding hypoxia-regulated tumor growth and metastasis.
    Wang X; Zhao D; Xie H; Hu Y
    Cancer Lett; 2021 Feb; 499():49-59. PubMed ID: 33217445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF-1 mediated metabolic reprogramming in cancer: Mechanisms and therapeutic implications.
    Taneja N; Chauhan A; Kulshreshtha R; Singh S
    Life Sci; 2024 Sep; 352():122890. PubMed ID: 38971364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-/HIF-1α-Driven Factors of the Tumor Microenvironment Impeding Antitumor Immune Responses and Promoting Malignant Progression.
    Vaupel P; Multhoff G
    Adv Exp Med Biol; 2018; 1072():171-175. PubMed ID: 30178341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies.
    Qiu GZ; Jin MZ; Dai JX; Sun W; Feng JH; Jin WL
    Trends Pharmacol Sci; 2017 Aug; 38(8):669-686. PubMed ID: 28602395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia: Intriguing Feature in Cancer Cell Biology.
    Chowdhury M; Das PK
    ChemMedChem; 2024 May; 19(9):e202300551. PubMed ID: 38328976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia and cancer cell metabolism.
    Huang D; Li C; Zhang H
    Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):214-9. PubMed ID: 24389642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory interferon activates HIF-1α-mediated epithelial-to-mesenchymal transition via PI3K/AKT/mTOR pathway.
    Yeh YH; Hsiao HF; Yeh YC; Chen TW; Li TK
    J Exp Clin Cancer Res; 2018 Mar; 37(1):70. PubMed ID: 29587825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment.
    Frolova O; Samudio I; Benito JM; Jacamo R; Kornblau SM; Markovic A; Schober W; Lu H; Qiu YH; Buglio D; McQueen T; Pierce S; Shpall E; Konoplev S; Thomas D; Kantarjian H; Lock R; Andreeff M; Konopleva M
    Cancer Biol Ther; 2012 Aug; 13(10):858-70. PubMed ID: 22785211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxic Effects on Matrix Metalloproteinases' Expression in the Tumor Microenvironment and Therapeutic Perspectives.
    Gonzalez-Avila G; Sommer B; Flores-Soto E; Aquino-Galvez A
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment.
    Seo J; Yun JE; Kim SJ; Chun YS
    Pflugers Arch; 2022 Jun; 474(6):591-601. PubMed ID: 35348849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1α signaling.
    Jones RB; Dorsett KA; Hjelmeland AB; Bellis SL
    J Biol Chem; 2018 Apr; 293(15):5659-5667. PubMed ID: 29475939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate.
    Merlo A; Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Pitiot AS; Balbín M; Astudillo A; Valdés N; Scola B; Del Toro R; Méndez-Ferrer S; Piruat JI; Suarez C; Chiara MD
    Oncotarget; 2017 Jan; 8(4):6700-6717. PubMed ID: 28036268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
    De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
    Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intriguing interplay between therapies targeting the epidermal growth factor receptor, the hypoxic microenvironment and hypoxia-inducible factors.
    Wouters A; Boeckx C; Vermorken JB; Van den Weyngaert D; Peeters M; Lardon F
    Curr Pharm Des; 2013; 19(5):907-17. PubMed ID: 22973959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunomodulation in the tumor microenvironment: Therapeutic potential of combined inhibition of tumor hypoxia and PD-1/ PD-L1].
    Svajda L; Cserepes M; Hegyi B; Niczky T; Tóvári J
    Magy Onkol; 2024 Jul; 68(2):126-135. PubMed ID: 39013086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
    Rohwer N; Cramer T
    Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
    Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
    J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection.
    Hatfield SM; Kjaergaard J; Lukashev D; Belikoff B; Schreiber TH; Sethumadhavan S; Abbott R; Philbrook P; Thayer M; Shujia D; Rodig S; Kutok JL; Ren J; Ohta A; Podack ER; Karger B; Jackson EK; Sitkovsky M
    J Mol Med (Berl); 2014 Dec; 92(12):1283-92. PubMed ID: 25120128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment.
    Zhi S; Chen C; Huang H; Zhang Z; Zeng F; Zhang S
    Front Immunol; 2024; 15():1370800. PubMed ID: 38799423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.